Peripheral inflammatory cytokines and immune balance in Generalised Anxiety Disorder: Case-controlled study

[1]  R. Dantzer,et al.  Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions , 2016, Molecular Psychiatry.

[2]  Andrew H. Miller,et al.  The role of inflammation in depression: from evolutionary imperative to modern treatment target , 2015, Nature Reviews Immunology.

[3]  Ives Cavalcante Passos,et al.  Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. , 2015, The lancet. Psychiatry.

[4]  N. Schmitz,et al.  The longitudinal associations between C‐reactive protein and depressive symptoms: evidence from the English Longitudinal Study of Ageing (ELSA) , 2015, International journal of geriatric psychiatry.

[5]  M. Strippoli,et al.  Evidence for Chronic Low-Grade Systemic Inflammation in Individuals with Agoraphobia from a Population-Based Prospective Study , 2015, PloS one.

[6]  O. Mors,et al.  Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. , 2014, JAMA psychiatry.

[7]  Álvaro Camacho.  Is anxious-depression an inflammatory state? , 2013, Medical hypotheses.

[8]  M. Maes,et al.  So depression is an inflammatory disease, but where does the inflammation come from? , 2013, BMC Medicine.

[9]  D. Baldwin,et al.  Potential neuroimmunological targets in the treatment of anxiety disorders. , 2013, Modern trends in pharmacopsychiatry.

[10]  P. Mortensen,et al.  Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. , 2013, JAMA psychiatry.

[11]  D. Wilcock,et al.  Are inflammatory profiles the key to personalized Alzheimer's treatment? , 2013, Neurodegenerative disease management.

[12]  P de Jonge,et al.  Anxiety disorders and inflammation in a large adult cohort , 2013, Translational Psychiatry.

[13]  D. F. Drake,et al.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.

[14]  B. Bogerts,et al.  Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[15]  M. Maes,et al.  Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways , 2012, BMC Medicine.

[16]  E. Costello,et al.  Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis , 2012, Psychological Medicine.

[17]  M. Bloch,et al.  Systematic Review of Proinflammatory Cytokines in Obsessive-Compulsive Disorder , 2012, Current Psychiatry Reports.

[18]  L. Vécsei,et al.  The kynurenine system and immunoregulation , 2012, Journal of Neural Transmission.

[19]  V. Meyer-Rochow,et al.  The association between anxiety and C-reactive protein (CRP) levels: Results from the Northern Finland 1966 Birth Cohort Study , 2011, European Psychiatry.

[20]  J. Os,et al.  The size and burden of mental disorders and other disorders of the brain in Europe 2010 , 2011, European Neuropsychopharmacology.

[21]  Andrew H. Miller,et al.  Immune system to brain signaling: neuropsychopharmacological implications. , 2011, Pharmacology & therapeutics.

[22]  R. Andrade,et al.  Enhanced Th17 phenotype in individuals with generalized anxiety disorder , 2010, Journal of Neuroimmunology.

[23]  George M. Slavich,et al.  Clinical anxiety, cortisol and interleukin-6: Evidence for specificity in emotion–biology relationships , 2010, Brain, Behavior, and Immunity.

[24]  M. Schwarz,et al.  Immune System and Schizophrenia. , 2010, Current immunology reviews.

[25]  H. Westenberg,et al.  Lipopolysaccharide-induced cytokine production in obsessive–compulsive disorder and generalized social anxiety disorder , 2010, Psychiatry Research.

[26]  B. Wagner,et al.  Interferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foals , 2010, Veterinary research.

[27]  B. Morasco,et al.  Neuroimmune mechanisms of cytokine-induced depression: Current theories and novel treatment strategies , 2010, Neurobiology of Disease.

[28]  Naomi I. Eisenberger,et al.  Anger and fear responses to stress have different biological profiles , 2010, Brain, Behavior, and Immunity.

[29]  Henry Völzke,et al.  Association of posttraumatic stress disorder with low-grade elevation of C-reactive protein: evidence from the general population. , 2010, Journal of psychiatric research.

[30]  J. Gill,et al.  PTSD is associated with an excess of inflammatory immune activities. , 2009, Perspectives in psychiatric care.

[31]  V. Seyfert-Margolis,et al.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays , 2009, BMC Immunology.

[32]  N. Simon,et al.  Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder , 2009, Depression and anxiety.

[33]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[34]  B. Leonard,et al.  The psychoneuroimmunology of depression , 2009, Human psychopharmacology.

[35]  M. Peck,et al.  Th1/Th2 Patterns and Balance in Cytokine Production in the Parents and Infants of a Large Birth Cohort1 , 2009, The Journal of Immunology.

[36]  J. Januzzi,et al.  Association between C-reactive protein and generalized anxiety disorder in stable coronary heart disease patients. , 2008, European heart journal.

[37]  M G Marmot,et al.  Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study , 2008, Psychological Medicine.

[38]  M. McGee,et al.  Mental-physical comorbidity in an ethnically diverse population. , 2008, Social science & medicine.

[39]  H. Wittchen,et al.  Human and economic burden of generalized anxiety disorder , 2008, Depression and anxiety.

[40]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[41]  M. Schwarz,et al.  The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression , 2007, Molecular Psychiatry.

[42]  N. Müller,et al.  Immunologische Aspekte bei depressiven Störungen , 2007, Der Nervenarzt.

[43]  A. Steptoe,et al.  The effects of acute psychological stress on circulating inflammatory factors in humans: A review and meta-analysis , 2007, Brain, Behavior, and Immunity.

[44]  N. Atasoy,et al.  Plasma Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Obsessive Compulsive Disorder , 2007, Mediators of inflammation.

[45]  M. Schwarz,et al.  The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. , 2007, Journal of neural transmission. Supplementum.

[46]  N. Müller,et al.  [Immunological aspects of depressive disorders]. , 2007, Der Nervenarzt.

[47]  C. Sommer,et al.  Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. , 2006, Arthritis and rheumatism.

[48]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[49]  D. Panagiotakos,et al.  Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. , 2006, Atherosclerosis.

[50]  Andrew H. Miller,et al.  Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.

[51]  R. Kessler,et al.  Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. , 2004, JAMA.

[52]  M. Maes,et al.  Neuroimmunological parameters in panic disorder , 2004, Acta Neuropsychiatrica.

[53]  S. Maier.  Bi-directional immune–brain communication: Implications for understanding stress, pain, and cognition , 2003, Brain, Behavior, and Immunity.

[54]  M. Kemeny.  An interdisciplinary research model to investigate psychosocial cofactors in disease: Application to HIV-1 pathogenesis , 2003, Brain, Behavior, and Immunity.

[55]  D. Witte,et al.  Interferon-gamma:interleukin 4 ratios and associated type 1 cytokine expression in juvenile rheumatoid arthritis synovial tissue. , 2002, The Journal of rheumatology.

[56]  M. Fava,et al.  The Anxiety Sensitivity Index: Item Analysis and Suggestions for Refinement , 2001, Journal of personality assessment.

[57]  E. Bosmans,et al.  Anti-Inflammatory Effects of Antidepressants Through Suppression of the Interferon-γ/Interleukin-10 Production Ratio , 2001, Journal of clinical psychopharmacology.

[58]  D. Remick,et al.  Cytokines and the brain: implications for clinical psychiatry. , 2000, The American journal of psychiatry.

[59]  Andreas Radbruch,et al.  The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. , 1999, Rheumatology.

[60]  R. Weizman,et al.  Cytokine production in panic disorder patients. , 1999, Clinical neuropharmacology.

[61]  G. Marshall,et al.  Cytokine Dysregulation Associated with Exam Stress in Healthy Medical Students , 1998, Brain, Behavior, and Immunity.

[62]  M. Maj,et al.  Decreased Blood Levels of Tumor Necrosis Factor-Alpha in Patients with Obsessive-Compulsive Disorder , 1998, Neuropsychobiology.

[63]  E. Bosmans,et al.  The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. , 1998, Cytokine.

[64]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[65]  T. Tabuchi,et al.  Immune function and lifestyle of taxi drivers in Japan. , 1998, Industrial health.

[66]  A. von Ruecker,et al.  Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. , 1996, Surgery.

[67]  Michael Maes,et al.  Evidence for an immune response in major depression: A review and hypothesis , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[68]  R. Ader,et al.  Psychoneuroimmunology: interactions between the nervous system and the immune system , 1995, The Lancet.

[69]  P. Sacerdote,et al.  Plasma interleukin-1 beta concentrations in panic disorder , 1994, Psychiatry Research.

[70]  P. Cosyns,et al.  Immune disorders in depression: higher T helper/T suppressor‐cytotoxic cell ratio , 1992, Acta psychiatrica Scandinavica.

[71]  E. Bosmans,et al.  Disturbances in acute phase plasma proteins during melancholia: Additional evidence for the presence of an inflammatory process during that illness , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[72]  E. Bosmans,et al.  Depression‐related disturbances in mitogen‐induced lymphocyte responses and interleukin‐1β and soluble interleukin‐2 receptor production , 1991, Acta psychiatrica Scandinavica.

[73]  E. Bosmans,et al.  Immune disturbances during major depression: upregulated expression of interleukin-2 receptors. , 1990, Neuropsychobiology.

[74]  R. Snaith,et al.  The hospital anxiety and depression scale. , 2013, Acta psychiatrica Scandinavica.

[75]  T. Kamarck,et al.  A global measure of perceived stress. , 1983, Journal of health and social behavior.

[76]  R Ader,et al.  Behaviorally Conditioned Immunosuppression , 1974, Psychosomatic medicine.